(redirected from Fluorodeoxyglucose)
Also found in: Medical, Wikipedia.
FDGFoundations of Digital Games
FDGFundação de Desenvolvimento Gerencial
FDGFunction Dependence Graph
FDGFunctional Dependency Gate
FDGFront des Gaulois
FDGFalling Down Giggling
FDGFamily Dental Group, PC
FDGF-Labeled 2-Deoxyglucose
FDGFraud Detection Group
FDGF-18-Deoxyglucose or Fluorodeoxyglucose (radiopharmaceutical)
FDGForces Démocratiques de la Guyane (French: Guyana Democratic Forces)
FDGFood & Drink Group (various organizations)
FDGFranchise Development Group
References in periodicals archive ?
That five hours needed to produce the tagged probe fluorodeoxyglucose (FDG) at Lawson, for example, fills a binder of documentation distinguishing it from FDG produced by CPDC with a cyclotron on the McMaster campus.
Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography.
Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography.
F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Positron emission tomographic scan showed no uptake of F-18 fluorodeoxyglucose in the nodule, lungs, or mediastinum.
Patients in the study will receive a SPECT scan with 99mTc-EC-G, and a PET scan (Positron Emission Tomography) with fluorine-18 FluoroDeoxyGlucose (18F-FDG).
For instance, it is expected that an increasing number of oncology and cardiology procedures will drive the demand for radiopharmaceuticals such as fluorodeoxyglucose used for PET scans.
TEHRAN (FNA)- Iran has set up a unit to produce oxygen-18 isotope which is an important precursor for the production of fluorodeoxyglucose used in positron emission tomography, Head of the Atomic Energy Organization of Iran (AEOI) Ali Akbar Salehi announced on Wednesday.
Metastatic choriocarcinoma with tumor thrombus in the right atrium and pulmonary vessels: diagnosis and therapy monitoring with F-18 fluorodeoxyglucose PET/CT.
True (A) or false (B)--click on the correct answer: Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is an accurate test in differentiating benign from malignant solitary pulmonary nodules.
Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.